insights_auto
Why is VCEL up 2.12%?
Dive Deeperchevron_right
VCEL:NASDAQ
Vericel Corp
$41.10
arrow_upward
+2.12%(+0.85) 1D
Oct 15, 3:20:49 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VCEL...
Open
$40.77
High
$41.60
Low
$40.26
Mkt. cap
2.10B
Avg. vol.
514.82K
Volume
276.40K
P/E ratio
98.41
52-wk high
$49.32
52-wk low
$28.95
EPS
$0.42
Beta
1.02
Shares outstanding
51.21M
No. of employees
398
Open
$40.77
High
$41.60
Low
$40.26
Mkt. cap
2.10B
Avg. vol.
514.82K
Volume
276.40K
P/E ratio
98.41
52-wk high
$49.32
52-wk low
$28.95
EPS
$0.42
Beta
1.02
Shares outstanding
51.21M
No. of employees
398
News stories
From web sources and news partners
Stock Traders Daily
·
1 day ago
(VCEL) Movement as an Input in Quant Signal Sets
Profile
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before.
In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts. Wikipedia
About Vericel Corp
CEONick Colangelo
Employees398
Founded1989
HeadquartersCambridge, Massachusetts, United States
SectorBiotechnology
Websitevcel.com